According to the report, the size of the Asia Pacific Atrial Fibrillation Surgery Market is valued at USD 164.9 million in 2019, and is expected to grow at a CAGR of 17.2%, to reach USD 363.9 million by 2024 during the forecast period 2019-2024.
Atrial Fibrillation is an abnormal rhythm or quivering of the heart caused by irregular beating of the atria. This condition of heart can lead to stroke, blood clots, heart failure and other heart related issues. The symptoms include fainting, chest pain, shortness of breath and heart palpitations.
Atrial fibrillation, if left untreated doubles the risk of heart related deaths and stokes in humans. Treatment for atrial fibrillation includes rhythm control, heart rate control, preventing heart failure and blood clots. But treatment and medication doesn’t work in all cases. In that case, surgical procedure is conducted to destroy the heart tissue in the area that is causing erratic electrical signals and restore the heart to a normal rhythm either by using catheters or during an open heart surgery.
Growing number of atrial fibrillation cases all over the globe is the major factor driving this market. Lower treatment costs and reimbursement policies are expected to drive the market. Favourable regulations and increasing preference for surgeries are also driving the market. However, lack of awareness about surgeries or health risks posed by atrial fibrillation among the people suffering from the issue and availability of several pharmaceutical alternatives are restraining the market.
Asia Pacific Atrial Fibrillation Surgery Market has been segmented and sub-segmented into the following categories
On the basis of region, the Asia Pacific is expected to be the fastest growing segment due to the large number of geriatric population who has a high risk of heart diseases in countries such as India and China.
Top Companies leading the Asia Pacific Atrial Fibrillation Surgery Market profiled in the Report are Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Medtronic, Inc., Cardima, Inc. Cardiofocus, Inc., nContact, Inc., and Biotronik SE & Co
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Surgical Procedure
5.1.1 Introduction
5.1.2 Catheter Ablation Procedures
5.1.3 Surgical Ablation/Maze Procedures
5.1.4 Y-o-Y Growth Analysis, By Surgical Procedure
5.1.5 Market Attractiveness Analysis, By Surgical Procedure
5.1.6 Market Share Analysis, By Surgical Procedure
5.2 Product
5.2.1 Introduction
5.2.2 Catheter Ablation Device
5.2.3 Surgical Ablation Device
5.2.4 Y-o-Y Growth Analysis, By Product
5.2.5 Market Attractiveness Analysis, By Product
5.2.6 Market Share Analysis, By Product
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Surgical Procedure
6.1.3.3 By Product
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Surgical Procedure
6.1.4.3 By Product
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Surgical Procedure
6.1.5.3 By Product
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of APAC
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Biosense Webster, Inc.
8.3 Boston Scientific CorporationInternational
8.4 St. Jude Medical, Inc.
8.5 Cardiofocus, Inc.
8.6 Atricure, Inc.
8.7 Carima, Inc.
8.8 Ncontact, Inc.
8.9 Biotroik Se & Co.Kg
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
